Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Cited In for PubMed (Select 10496243)

1.

Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease.

Clark LN, Chan R, Cheng R, Liu X, Park N, Parmalee N, Kisselev S, Cortes E, Torres PA, Pastores GM, Vonsattel JP, Alcalay R, Marder K, Honig LL, Fahn S, Mayeux R, Shelanski M, Di Paolo G, Lee JH.

PLoS One. 2015 May 1;10(5):e0125204. doi: 10.1371/journal.pone.0125204. eCollection 2015.

2.

Imaging Amyloidopathy in Parkinson Disease and Parkinsonian Dementia Syndromes.

Frey KA, Petrou M.

Clin Transl Imaging. 2015 Feb 1;3(1):57-64.

PMID:
25745616
3.

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease.

Silajdžić E, Björkqvist M, Hansson O.

BMC Neurol. 2015 Feb 5;15:8. doi: 10.1186/s12883-015-0260-1.

4.

Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease.

Babiloni C, Del Percio C, Boccardi M, Lizio R, Lopez S, Carducci F, Marzano N, Soricelli A, Ferri R, Triggiani AI, Prestia A, Salinari S, Rasser PE, Basar E, Famà F, Nobili F, Yener G, Emek-Savaş DD, Gesualdo L, Mundi C, Thompson PM, Rossini PM, Frisoni GB.

Neurobiol Aging. 2015 Feb;36(2):556-70. doi: 10.1016/j.neurobiolaging.2014.09.011. Epub 2014 Sep 21.

PMID:
25442118
5.

Prevalence of mixed pathologies in the aging brain.

Rahimi J, Kovacs GG.

Alzheimers Res Ther. 2014 Nov 21;6(9):82. doi: 10.1186/s13195-014-0082-1. eCollection 2014.

6.

Lewy body disease and dementia with Lewy bodies.

Kosaka K.

Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(8):301-6. Review.

7.

Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, Provenzano FA, Schupf N, Manly JJ, Stern Y, Luchsinger JA, Mayeux R.

Neurobiol Aging. 2015 Jan;36(1):27-32. doi: 10.1016/j.neurobiolaging.2014.07.019. Epub 2014 Jul 21.

PMID:
25155654
8.

Magnetic resonance spectroscopy in the diagnosis of dementia with Lewy bodies.

Magierski R, Sobow T.

Biomed Res Int. 2014;2014:809503. doi: 10.1155/2014/809503. Epub 2014 Jul 6. Review.

9.

The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.

Linnertz C, Lutz MW, Ervin JF, Allen J, Miller NR, Welsh-Bohmer KA, Roses AD, Chiba-Falek O.

Hum Mol Genet. 2014 Sep 15;23(18):4814-21. doi: 10.1093/hmg/ddu196. Epub 2014 Apr 28.

PMID:
24777780
10.

Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease.

Hertze J, Palmqvist S, Minthon L, Hansson O.

Dement Geriatr Cogn Dis Extra. 2013 Apr 19;3(1):113-22. doi: 10.1159/000348353. Print 2013 Jan.

11.

No diagnostic value of plasma clusterin in Alzheimer's disease.

Silajdžić E, Minthon L, Björkqvist M, Hansson O.

PLoS One. 2012;7(11):e50237. doi: 10.1371/journal.pone.0050237. Epub 2012 Nov 28.

12.

Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.

Brickman AM, Provenzano FA, Muraskin J, Manly JJ, Blum S, Apa Z, Stern Y, Brown TR, Luchsinger JA, Mayeux R.

Arch Neurol. 2012 Dec;69(12):1621-7. doi: 10.1001/archneurol.2012.1527.

13.

Characterizing cognitive deficits and dementia in an aging urban population in India.

Nair G, Van Dyk K, Shah U, Purohit DP, Pinto C, Shah AB, Grossman H, Perl D, Ganwir V, Shanker S, Sano M.

Int J Alzheimers Dis. 2012;2012:673849. doi: 10.1155/2012/673849. Epub 2012 Jun 27.

14.

Overview and findings from the rush Memory and Aging Project.

Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS.

Curr Alzheimer Res. 2012 Jul;9(6):646-63.

15.

Overview and findings from the religious orders study.

Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS.

Curr Alzheimer Res. 2012 Jul;9(6):628-45.

16.

Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders.

Kotagal V, Müller ML, Kaufer DI, Koeppe RA, Bohnen NI.

Neurosci Lett. 2012 Apr 18;514(2):169-72. doi: 10.1016/j.neulet.2012.02.083. Epub 2012 Mar 3.

17.

Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathies.

Lue LF, Walker DG, Adler CH, Shill H, Tran H, Akiyama H, Sue LI, Caviness J, Sabbagh MN, Beach TG.

Brain Pathol. 2012 Nov;22(6):745-56. doi: 10.1111/j.1750-3639.2012.00585.x. Epub 2012 Apr 12.

18.

Are clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race?

Teresi JA, Grober E, Eimicke JP, Ehrlich AR.

Psychol Assess. 2012 Sep;24(3):531-44. doi: 10.1037/a0027008. Epub 2012 Feb 6.

19.

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde Rikkert M, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jönhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H.

Neurology. 2012 Feb 14;78(7):468-76. doi: 10.1212/WNL.0b013e3182477eed. Epub 2012 Feb 1.

20.

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease.

Björkqvist M, Ohlsson M, Minthon L, Hansson O.

PLoS One. 2012;7(1):e29868. doi: 10.1371/journal.pone.0029868. Epub 2012 Jan 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk